nodes	percent_of_prediction	percent_of_DWPC	metapath
Atazanavir—Cytochrome P450 3A Inhibitors—Crizotinib—lung cancer	0.522	1	CiPCiCtD
Atazanavir—ABCB1—lung cancer	0.0902	1	CbGaD
Atazanavir—SLCO1B3—Paclitaxel—lung cancer	0.0259	0.0923	CbGbCtD
Atazanavir—SLCO1B3—Docetaxel—lung cancer	0.0187	0.0667	CbGbCtD
Atazanavir—ABCC1—Paclitaxel—lung cancer	0.0179	0.0638	CbGbCtD
Atazanavir—ABCC1—Irinotecan—lung cancer	0.0177	0.0629	CbGbCtD
Atazanavir—ABCC1—Vinblastine—lung cancer	0.0157	0.0559	CbGbCtD
Atazanavir—ABCC1—Etoposide—lung cancer	0.0142	0.0504	CbGbCtD
Atazanavir—SLCO1B3—Methotrexate—lung cancer	0.0135	0.0482	CbGbCtD
Atazanavir—ABCC1—Docetaxel—lung cancer	0.013	0.0461	CbGbCtD
Atazanavir—ABCC1—Doxorubicin—lung cancer	0.00966	0.0344	CbGbCtD
Atazanavir—ABCC1—Methotrexate—lung cancer	0.00936	0.0333	CbGbCtD
Atazanavir—ABCB1—Topotecan—lung cancer	0.00873	0.0311	CbGbCtD
Atazanavir—CYP2C9—Gefitinib—lung cancer	0.00823	0.0293	CbGbCtD
Atazanavir—ABCB1—Gefitinib—lung cancer	0.00799	0.0284	CbGbCtD
Atazanavir—CYP2C9—Teniposide—lung cancer	0.00798	0.0284	CbGbCtD
Atazanavir—ABCB1—Vinorelbine—lung cancer	0.00615	0.0219	CbGbCtD
Atazanavir—CYP3A4—Topotecan—lung cancer	0.00523	0.0186	CbGbCtD
Atazanavir—ABCB1—Crizotinib—lung cancer	0.0049	0.0174	CbGbCtD
Atazanavir—CYP3A4—Gefitinib—lung cancer	0.00479	0.017	CbGbCtD
Atazanavir—ABCB1—Gemcitabine—lung cancer	0.00479	0.017	CbGbCtD
Atazanavir—ABCB1—Erlotinib—lung cancer	0.00472	0.0168	CbGbCtD
Atazanavir—CYP3A4—Teniposide—lung cancer	0.00464	0.0165	CbGbCtD
Atazanavir—CYP2C9—Paclitaxel—lung cancer	0.00446	0.0159	CbGbCtD
Atazanavir—ABCB1—Paclitaxel—lung cancer	0.00432	0.0154	CbGbCtD
Atazanavir—ABCB1—Irinotecan—lung cancer	0.00427	0.0152	CbGbCtD
Atazanavir—ABCB1—Vinblastine—lung cancer	0.00379	0.0135	CbGbCtD
Atazanavir—CYP3A4—Vinorelbine—lung cancer	0.00369	0.0131	CbGbCtD
Atazanavir—CYP2C9—Cisplatin—lung cancer	0.00358	0.0128	CbGbCtD
Atazanavir—ABCB1—Cisplatin—lung cancer	0.00348	0.0124	CbGbCtD
Atazanavir—ABCB1—Etoposide—lung cancer	0.00342	0.0122	CbGbCtD
Atazanavir—ABCB1—Docetaxel—lung cancer	0.00313	0.0111	CbGbCtD
Atazanavir—CYP3A4—Crizotinib—lung cancer	0.00293	0.0104	CbGbCtD
Atazanavir—CYP3A4—Erlotinib—lung cancer	0.00283	0.0101	CbGbCtD
Atazanavir—CYP3A4—Paclitaxel—lung cancer	0.00259	0.00922	CbGbCtD
Atazanavir—CYP3A4—Irinotecan—lung cancer	0.00256	0.0091	CbGbCtD
Atazanavir—ABCB1—Doxorubicin—lung cancer	0.00233	0.00829	CbGbCtD
Atazanavir—CYP3A4—Vinblastine—lung cancer	0.00227	0.00809	CbGbCtD
Atazanavir—ABCB1—Methotrexate—lung cancer	0.00226	0.00804	CbGbCtD
Atazanavir—CYP3A4—Etoposide—lung cancer	0.00205	0.00729	CbGbCtD
Atazanavir—CYP3A4—Docetaxel—lung cancer	0.00187	0.00667	CbGbCtD
Atazanavir—CYP3A4—Doxorubicin—lung cancer	0.0014	0.00497	CbGbCtD
Atazanavir—Ritonavir—ABCG2—lung cancer	0.000367	0.243	CrCbGaD
Atazanavir—Ritonavir—CYP2E1—lung cancer	0.000292	0.193	CrCbGaD
Atazanavir—Saquinavir—ABCG2—lung cancer	0.000278	0.184	CrCbGaD
Atazanavir—Lopinavir—ABCB1—lung cancer	0.000182	0.12	CrCbGaD
Atazanavir—Ritonavir—ABCB1—lung cancer	0.000153	0.101	CrCbGaD
Atazanavir—Saquinavir—ALB—lung cancer	0.000121	0.0804	CrCbGaD
Atazanavir—Saquinavir—ABCB1—lung cancer	0.000116	0.0768	CrCbGaD
Atazanavir—Somnolence—Etoposide—lung cancer	3.14e-05	0.000386	CcSEcCtD
Atazanavir—Cough—Docetaxel—lung cancer	3.14e-05	0.000386	CcSEcCtD
Atazanavir—Hepatobiliary disease—Methotrexate—lung cancer	3.13e-05	0.000386	CcSEcCtD
Atazanavir—Insomnia—Paclitaxel—lung cancer	3.13e-05	0.000385	CcSEcCtD
Atazanavir—Hypersensitivity—Irinotecan—lung cancer	3.13e-05	0.000385	CcSEcCtD
Atazanavir—Convulsion—Docetaxel—lung cancer	3.11e-05	0.000383	CcSEcCtD
Atazanavir—Hypertension—Docetaxel—lung cancer	3.1e-05	0.000382	CcSEcCtD
Atazanavir—Dyspnoea—Paclitaxel—lung cancer	3.08e-05	0.00038	CcSEcCtD
Atazanavir—Somnolence—Paclitaxel—lung cancer	3.08e-05	0.000379	CcSEcCtD
Atazanavir—Decreased appetite—Etoposide—lung cancer	3.07e-05	0.000378	CcSEcCtD
Atazanavir—Arthralgia—Docetaxel—lung cancer	3.06e-05	0.000376	CcSEcCtD
Atazanavir—Chest pain—Docetaxel—lung cancer	3.06e-05	0.000376	CcSEcCtD
Atazanavir—Myalgia—Docetaxel—lung cancer	3.06e-05	0.000376	CcSEcCtD
Atazanavir—Nausea—Vinorelbine—lung cancer	3.06e-05	0.000376	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Etoposide—lung cancer	3.05e-05	0.000375	CcSEcCtD
Atazanavir—Dyspepsia—Paclitaxel—lung cancer	3.05e-05	0.000375	CcSEcCtD
Atazanavir—Body temperature increased—Cisplatin—lung cancer	3.04e-05	0.000375	CcSEcCtD
Atazanavir—Asthenia—Irinotecan—lung cancer	3.04e-05	0.000375	CcSEcCtD
Atazanavir—Fatigue—Etoposide—lung cancer	3.04e-05	0.000374	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—lung cancer	3.04e-05	0.000374	CcSEcCtD
Atazanavir—Constipation—Etoposide—lung cancer	3.02e-05	0.000371	CcSEcCtD
Atazanavir—Pain—Etoposide—lung cancer	3.02e-05	0.000371	CcSEcCtD
Atazanavir—Neutropenia—Doxorubicin—lung cancer	3.01e-05	0.00037	CcSEcCtD
Atazanavir—Decreased appetite—Paclitaxel—lung cancer	3.01e-05	0.00037	CcSEcCtD
Atazanavir—Dry mouth—Docetaxel—lung cancer	2.99e-05	0.000368	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Paclitaxel—lung cancer	2.99e-05	0.000368	CcSEcCtD
Atazanavir—Fatigue—Paclitaxel—lung cancer	2.98e-05	0.000367	CcSEcCtD
Atazanavir—Hepatitis—Methotrexate—lung cancer	2.97e-05	0.000366	CcSEcCtD
Atazanavir—Pollakiuria—Doxorubicin—lung cancer	2.97e-05	0.000366	CcSEcCtD
Atazanavir—Asthenia—Gemcitabine—lung cancer	2.96e-05	0.000365	CcSEcCtD
Atazanavir—Pain—Paclitaxel—lung cancer	2.96e-05	0.000364	CcSEcCtD
Atazanavir—Constipation—Paclitaxel—lung cancer	2.96e-05	0.000364	CcSEcCtD
Atazanavir—Confusional state—Docetaxel—lung cancer	2.96e-05	0.000364	CcSEcCtD
Atazanavir—Urinary tract disorder—Methotrexate—lung cancer	2.94e-05	0.000362	CcSEcCtD
Atazanavir—Photosensitivity reaction—Doxorubicin—lung cancer	2.94e-05	0.000362	CcSEcCtD
Atazanavir—Oedema—Docetaxel—lung cancer	2.93e-05	0.000361	CcSEcCtD
Atazanavir—Weight increased—Doxorubicin—lung cancer	2.93e-05	0.00036	CcSEcCtD
Atazanavir—Pruritus—Gemcitabine—lung cancer	2.92e-05	0.00036	CcSEcCtD
Atazanavir—Urethral disorder—Methotrexate—lung cancer	2.92e-05	0.000359	CcSEcCtD
Atazanavir—Infection—Docetaxel—lung cancer	2.91e-05	0.000359	CcSEcCtD
Atazanavir—Weight decreased—Doxorubicin—lung cancer	2.91e-05	0.000358	CcSEcCtD
Atazanavir—Feeling abnormal—Etoposide—lung cancer	2.91e-05	0.000358	CcSEcCtD
Atazanavir—Hyperglycaemia—Doxorubicin—lung cancer	2.9e-05	0.000357	CcSEcCtD
Atazanavir—Diarrhoea—Irinotecan—lung cancer	2.9e-05	0.000357	CcSEcCtD
Atazanavir—Gastrointestinal pain—Etoposide—lung cancer	2.89e-05	0.000355	CcSEcCtD
Atazanavir—Shock—Docetaxel—lung cancer	2.88e-05	0.000355	CcSEcCtD
Atazanavir—Nervous system disorder—Docetaxel—lung cancer	2.88e-05	0.000354	CcSEcCtD
Atazanavir—Feeling abnormal—Paclitaxel—lung cancer	2.85e-05	0.000351	CcSEcCtD
Atazanavir—Skin disorder—Docetaxel—lung cancer	2.85e-05	0.000351	CcSEcCtD
Atazanavir—Stevens-Johnson syndrome—Doxorubicin—lung cancer	2.84e-05	0.00035	CcSEcCtD
Atazanavir—Hypersensitivity—Cisplatin—lung cancer	2.84e-05	0.000349	CcSEcCtD
Atazanavir—Gastrointestinal pain—Paclitaxel—lung cancer	2.83e-05	0.000348	CcSEcCtD
Atazanavir—Diarrhoea—Gemcitabine—lung cancer	2.83e-05	0.000348	CcSEcCtD
Atazanavir—Renal failure—Doxorubicin—lung cancer	2.82e-05	0.000347	CcSEcCtD
Atazanavir—Erythema multiforme—Methotrexate—lung cancer	2.81e-05	0.000346	CcSEcCtD
Atazanavir—Neuropathy peripheral—Doxorubicin—lung cancer	2.81e-05	0.000346	CcSEcCtD
Atazanavir—Dizziness—Irinotecan—lung cancer	2.81e-05	0.000345	CcSEcCtD
Atazanavir—Urticaria—Etoposide—lung cancer	2.8e-05	0.000345	CcSEcCtD
Atazanavir—Stomatitis—Doxorubicin—lung cancer	2.8e-05	0.000344	CcSEcCtD
Atazanavir—Jaundice—Doxorubicin—lung cancer	2.8e-05	0.000344	CcSEcCtD
Atazanavir—Anorexia—Docetaxel—lung cancer	2.8e-05	0.000344	CcSEcCtD
Atazanavir—Abdominal pain—Etoposide—lung cancer	2.79e-05	0.000343	CcSEcCtD
Atazanavir—Body temperature increased—Etoposide—lung cancer	2.79e-05	0.000343	CcSEcCtD
Atazanavir—Urinary tract infection—Doxorubicin—lung cancer	2.79e-05	0.000343	CcSEcCtD
Atazanavir—Eye disorder—Methotrexate—lung cancer	2.78e-05	0.000342	CcSEcCtD
Atazanavir—Tinnitus—Methotrexate—lung cancer	2.77e-05	0.000341	CcSEcCtD
Atazanavir—Asthenia—Cisplatin—lung cancer	2.76e-05	0.00034	CcSEcCtD
Atazanavir—Cardiac disorder—Methotrexate—lung cancer	2.76e-05	0.00034	CcSEcCtD
Atazanavir—Sweating—Doxorubicin—lung cancer	2.75e-05	0.000339	CcSEcCtD
Atazanavir—Urticaria—Paclitaxel—lung cancer	2.75e-05	0.000338	CcSEcCtD
Atazanavir—Haematuria—Doxorubicin—lung cancer	2.74e-05	0.000337	CcSEcCtD
Atazanavir—Abdominal pain—Paclitaxel—lung cancer	2.73e-05	0.000337	CcSEcCtD
Atazanavir—Body temperature increased—Paclitaxel—lung cancer	2.73e-05	0.000337	CcSEcCtD
Atazanavir—Hepatobiliary disease—Doxorubicin—lung cancer	2.71e-05	0.000334	CcSEcCtD
Atazanavir—Angiopathy—Methotrexate—lung cancer	2.7e-05	0.000332	CcSEcCtD
Atazanavir—Vomiting—Irinotecan—lung cancer	2.7e-05	0.000332	CcSEcCtD
Atazanavir—Immune system disorder—Methotrexate—lung cancer	2.69e-05	0.000331	CcSEcCtD
Atazanavir—Mediastinal disorder—Methotrexate—lung cancer	2.68e-05	0.00033	CcSEcCtD
Atazanavir—Rash—Irinotecan—lung cancer	2.67e-05	0.000329	CcSEcCtD
Atazanavir—Dermatitis—Irinotecan—lung cancer	2.67e-05	0.000329	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Docetaxel—lung cancer	2.67e-05	0.000329	CcSEcCtD
Atazanavir—Headache—Irinotecan—lung cancer	2.66e-05	0.000327	CcSEcCtD
Atazanavir—Insomnia—Docetaxel—lung cancer	2.65e-05	0.000326	CcSEcCtD
Atazanavir—Diarrhoea—Cisplatin—lung cancer	2.64e-05	0.000324	CcSEcCtD
Atazanavir—Alopecia—Methotrexate—lung cancer	2.63e-05	0.000324	CcSEcCtD
Atazanavir—Vomiting—Gemcitabine—lung cancer	2.63e-05	0.000323	CcSEcCtD
Atazanavir—Dyspnoea—Docetaxel—lung cancer	2.61e-05	0.000322	CcSEcCtD
Atazanavir—Somnolence—Docetaxel—lung cancer	2.61e-05	0.000321	CcSEcCtD
Atazanavir—Mental disorder—Methotrexate—lung cancer	2.61e-05	0.000321	CcSEcCtD
Atazanavir—Rash—Gemcitabine—lung cancer	2.61e-05	0.000321	CcSEcCtD
Atazanavir—Dermatitis—Gemcitabine—lung cancer	2.6e-05	0.00032	CcSEcCtD
Atazanavir—Hypersensitivity—Etoposide—lung cancer	2.6e-05	0.00032	CcSEcCtD
Atazanavir—Malnutrition—Methotrexate—lung cancer	2.59e-05	0.000319	CcSEcCtD
Atazanavir—Headache—Gemcitabine—lung cancer	2.59e-05	0.000319	CcSEcCtD
Atazanavir—Dyspepsia—Docetaxel—lung cancer	2.58e-05	0.000318	CcSEcCtD
Atazanavir—Hepatitis—Doxorubicin—lung cancer	2.58e-05	0.000317	CcSEcCtD
Atazanavir—Hypoaesthesia—Doxorubicin—lung cancer	2.56e-05	0.000315	CcSEcCtD
Atazanavir—Decreased appetite—Docetaxel—lung cancer	2.55e-05	0.000314	CcSEcCtD
Atazanavir—Hypersensitivity—Paclitaxel—lung cancer	2.55e-05	0.000314	CcSEcCtD
Atazanavir—Urinary tract disorder—Doxorubicin—lung cancer	2.54e-05	0.000313	CcSEcCtD
Atazanavir—Oedema peripheral—Doxorubicin—lung cancer	2.54e-05	0.000312	CcSEcCtD
Atazanavir—Dysgeusia—Methotrexate—lung cancer	2.54e-05	0.000312	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Docetaxel—lung cancer	2.53e-05	0.000312	CcSEcCtD
Atazanavir—Asthenia—Etoposide—lung cancer	2.53e-05	0.000312	CcSEcCtD
Atazanavir—Connective tissue disorder—Doxorubicin—lung cancer	2.53e-05	0.000312	CcSEcCtD
Atazanavir—Fatigue—Docetaxel—lung cancer	2.53e-05	0.000311	CcSEcCtD
Atazanavir—Urethral disorder—Doxorubicin—lung cancer	2.53e-05	0.000311	CcSEcCtD
Atazanavir—Nausea—Irinotecan—lung cancer	2.52e-05	0.00031	CcSEcCtD
Atazanavir—Pain—Docetaxel—lung cancer	2.51e-05	0.000309	CcSEcCtD
Atazanavir—Constipation—Docetaxel—lung cancer	2.51e-05	0.000309	CcSEcCtD
Atazanavir—Back pain—Methotrexate—lung cancer	2.5e-05	0.000308	CcSEcCtD
Atazanavir—Pruritus—Etoposide—lung cancer	2.5e-05	0.000307	CcSEcCtD
Atazanavir—Asthenia—Paclitaxel—lung cancer	2.48e-05	0.000306	CcSEcCtD
Atazanavir—Nausea—Gemcitabine—lung cancer	2.45e-05	0.000302	CcSEcCtD
Atazanavir—Vomiting—Cisplatin—lung cancer	2.45e-05	0.000301	CcSEcCtD
Atazanavir—Pruritus—Paclitaxel—lung cancer	2.45e-05	0.000301	CcSEcCtD
Atazanavir—Erythema multiforme—Doxorubicin—lung cancer	2.44e-05	0.0003	CcSEcCtD
Atazanavir—Rash—Cisplatin—lung cancer	2.43e-05	0.000299	CcSEcCtD
Atazanavir—Dermatitis—Cisplatin—lung cancer	2.43e-05	0.000299	CcSEcCtD
Atazanavir—Feeling abnormal—Docetaxel—lung cancer	2.42e-05	0.000297	CcSEcCtD
Atazanavir—Diarrhoea—Etoposide—lung cancer	2.41e-05	0.000297	CcSEcCtD
Atazanavir—Eye disorder—Doxorubicin—lung cancer	2.41e-05	0.000296	CcSEcCtD
Atazanavir—Ill-defined disorder—Methotrexate—lung cancer	2.4e-05	0.000296	CcSEcCtD
Atazanavir—Tinnitus—Doxorubicin—lung cancer	2.4e-05	0.000296	CcSEcCtD
Atazanavir—Gastrointestinal pain—Docetaxel—lung cancer	2.4e-05	0.000295	CcSEcCtD
Atazanavir—Cardiac disorder—Doxorubicin—lung cancer	2.39e-05	0.000294	CcSEcCtD
Atazanavir—Diarrhoea—Paclitaxel—lung cancer	2.37e-05	0.000291	CcSEcCtD
Atazanavir—Angiopathy—Doxorubicin—lung cancer	2.34e-05	0.000288	CcSEcCtD
Atazanavir—Malaise—Methotrexate—lung cancer	2.34e-05	0.000287	CcSEcCtD
Atazanavir—Dizziness—Etoposide—lung cancer	2.33e-05	0.000287	CcSEcCtD
Atazanavir—Immune system disorder—Doxorubicin—lung cancer	2.33e-05	0.000286	CcSEcCtD
Atazanavir—Mediastinal disorder—Doxorubicin—lung cancer	2.32e-05	0.000286	CcSEcCtD
Atazanavir—Body temperature increased—Docetaxel—lung cancer	2.32e-05	0.000285	CcSEcCtD
Atazanavir—Abdominal pain—Docetaxel—lung cancer	2.32e-05	0.000285	CcSEcCtD
Atazanavir—Dizziness—Paclitaxel—lung cancer	2.29e-05	0.000282	CcSEcCtD
Atazanavir—Nausea—Cisplatin—lung cancer	2.29e-05	0.000282	CcSEcCtD
Atazanavir—Alopecia—Doxorubicin—lung cancer	2.28e-05	0.00028	CcSEcCtD
Atazanavir—Cough—Methotrexate—lung cancer	2.26e-05	0.000278	CcSEcCtD
Atazanavir—Mental disorder—Doxorubicin—lung cancer	2.26e-05	0.000278	CcSEcCtD
Atazanavir—Convulsion—Methotrexate—lung cancer	2.24e-05	0.000276	CcSEcCtD
Atazanavir—Vomiting—Etoposide—lung cancer	2.24e-05	0.000276	CcSEcCtD
Atazanavir—Malnutrition—Doxorubicin—lung cancer	2.24e-05	0.000276	CcSEcCtD
Atazanavir—Rash—Etoposide—lung cancer	2.22e-05	0.000274	CcSEcCtD
Atazanavir—Dermatitis—Etoposide—lung cancer	2.22e-05	0.000274	CcSEcCtD
Atazanavir—Headache—Etoposide—lung cancer	2.21e-05	0.000272	CcSEcCtD
Atazanavir—Flatulence—Doxorubicin—lung cancer	2.21e-05	0.000272	CcSEcCtD
Atazanavir—Chest pain—Methotrexate—lung cancer	2.2e-05	0.000271	CcSEcCtD
Atazanavir—Arthralgia—Methotrexate—lung cancer	2.2e-05	0.000271	CcSEcCtD
Atazanavir—Myalgia—Methotrexate—lung cancer	2.2e-05	0.000271	CcSEcCtD
Atazanavir—Tension—Doxorubicin—lung cancer	2.2e-05	0.000271	CcSEcCtD
Atazanavir—Vomiting—Paclitaxel—lung cancer	2.2e-05	0.000271	CcSEcCtD
Atazanavir—Dysgeusia—Doxorubicin—lung cancer	2.2e-05	0.00027	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—lung cancer	2.19e-05	0.000269	CcSEcCtD
Atazanavir—Rash—Paclitaxel—lung cancer	2.18e-05	0.000268	CcSEcCtD
Atazanavir—Dermatitis—Paclitaxel—lung cancer	2.18e-05	0.000268	CcSEcCtD
Atazanavir—Discomfort—Methotrexate—lung cancer	2.18e-05	0.000268	CcSEcCtD
Atazanavir—Nervousness—Doxorubicin—lung cancer	2.18e-05	0.000268	CcSEcCtD
Atazanavir—Back pain—Doxorubicin—lung cancer	2.17e-05	0.000267	CcSEcCtD
Atazanavir—Headache—Paclitaxel—lung cancer	2.17e-05	0.000267	CcSEcCtD
Atazanavir—Hypersensitivity—Docetaxel—lung cancer	2.16e-05	0.000266	CcSEcCtD
Atazanavir—Confusional state—Methotrexate—lung cancer	2.13e-05	0.000262	CcSEcCtD
Atazanavir—Asthenia—Docetaxel—lung cancer	2.1e-05	0.000259	CcSEcCtD
Atazanavir—Infection—Methotrexate—lung cancer	2.1e-05	0.000258	CcSEcCtD
Atazanavir—Nausea—Etoposide—lung cancer	2.1e-05	0.000258	CcSEcCtD
Atazanavir—Ill-defined disorder—Doxorubicin—lung cancer	2.08e-05	0.000256	CcSEcCtD
Atazanavir—Pruritus—Docetaxel—lung cancer	2.07e-05	0.000255	CcSEcCtD
Atazanavir—Nervous system disorder—Methotrexate—lung cancer	2.07e-05	0.000255	CcSEcCtD
Atazanavir—Agitation—Doxorubicin—lung cancer	2.06e-05	0.000254	CcSEcCtD
Atazanavir—Nausea—Paclitaxel—lung cancer	2.05e-05	0.000253	CcSEcCtD
Atazanavir—Skin disorder—Methotrexate—lung cancer	2.05e-05	0.000253	CcSEcCtD
Atazanavir—Hyperhidrosis—Methotrexate—lung cancer	2.04e-05	0.000251	CcSEcCtD
Atazanavir—Malaise—Doxorubicin—lung cancer	2.02e-05	0.000249	CcSEcCtD
Atazanavir—Anorexia—Methotrexate—lung cancer	2.01e-05	0.000248	CcSEcCtD
Atazanavir—Syncope—Doxorubicin—lung cancer	2.01e-05	0.000248	CcSEcCtD
Atazanavir—Diarrhoea—Docetaxel—lung cancer	2.01e-05	0.000247	CcSEcCtD
Atazanavir—Palpitations—Doxorubicin—lung cancer	1.98e-05	0.000244	CcSEcCtD
Atazanavir—Loss of consciousness—Doxorubicin—lung cancer	1.97e-05	0.000243	CcSEcCtD
Atazanavir—Cough—Doxorubicin—lung cancer	1.96e-05	0.000241	CcSEcCtD
Atazanavir—Convulsion—Doxorubicin—lung cancer	1.94e-05	0.000239	CcSEcCtD
Atazanavir—Dizziness—Docetaxel—lung cancer	1.94e-05	0.000239	CcSEcCtD
Atazanavir—Hypertension—Doxorubicin—lung cancer	1.94e-05	0.000238	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Methotrexate—lung cancer	1.93e-05	0.000237	CcSEcCtD
Atazanavir—Insomnia—Methotrexate—lung cancer	1.91e-05	0.000235	CcSEcCtD
Atazanavir—Chest pain—Doxorubicin—lung cancer	1.91e-05	0.000235	CcSEcCtD
Atazanavir—Arthralgia—Doxorubicin—lung cancer	1.91e-05	0.000235	CcSEcCtD
Atazanavir—Myalgia—Doxorubicin—lung cancer	1.91e-05	0.000235	CcSEcCtD
Atazanavir—Anxiety—Doxorubicin—lung cancer	1.9e-05	0.000234	CcSEcCtD
Atazanavir—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—lung cancer	1.9e-05	0.000233	CcSEcCtD
Atazanavir—Discomfort—Doxorubicin—lung cancer	1.89e-05	0.000232	CcSEcCtD
Atazanavir—Dyspnoea—Methotrexate—lung cancer	1.88e-05	0.000232	CcSEcCtD
Atazanavir—Somnolence—Methotrexate—lung cancer	1.88e-05	0.000231	CcSEcCtD
Atazanavir—Dry mouth—Doxorubicin—lung cancer	1.87e-05	0.00023	CcSEcCtD
Atazanavir—Vomiting—Docetaxel—lung cancer	1.86e-05	0.000229	CcSEcCtD
Atazanavir—Dyspepsia—Methotrexate—lung cancer	1.86e-05	0.000229	CcSEcCtD
Atazanavir—Rash—Docetaxel—lung cancer	1.85e-05	0.000228	CcSEcCtD
Atazanavir—Dermatitis—Docetaxel—lung cancer	1.85e-05	0.000227	CcSEcCtD
Atazanavir—Confusional state—Doxorubicin—lung cancer	1.85e-05	0.000227	CcSEcCtD
Atazanavir—Decreased appetite—Methotrexate—lung cancer	1.84e-05	0.000226	CcSEcCtD
Atazanavir—Headache—Docetaxel—lung cancer	1.84e-05	0.000226	CcSEcCtD
Atazanavir—Oedema—Doxorubicin—lung cancer	1.83e-05	0.000225	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Methotrexate—lung cancer	1.82e-05	0.000225	CcSEcCtD
Atazanavir—Fatigue—Methotrexate—lung cancer	1.82e-05	0.000224	CcSEcCtD
Atazanavir—Infection—Doxorubicin—lung cancer	1.82e-05	0.000224	CcSEcCtD
Atazanavir—Pain—Methotrexate—lung cancer	1.81e-05	0.000222	CcSEcCtD
Atazanavir—Shock—Doxorubicin—lung cancer	1.8e-05	0.000222	CcSEcCtD
Atazanavir—Nervous system disorder—Doxorubicin—lung cancer	1.79e-05	0.000221	CcSEcCtD
Atazanavir—Skin disorder—Doxorubicin—lung cancer	1.78e-05	0.000219	CcSEcCtD
Atazanavir—Hyperhidrosis—Doxorubicin—lung cancer	1.77e-05	0.000218	CcSEcCtD
Atazanavir—Anorexia—Doxorubicin—lung cancer	1.74e-05	0.000215	CcSEcCtD
Atazanavir—Nausea—Docetaxel—lung cancer	1.74e-05	0.000214	CcSEcCtD
Atazanavir—Feeling abnormal—Methotrexate—lung cancer	1.74e-05	0.000214	CcSEcCtD
Atazanavir—Gastrointestinal pain—Methotrexate—lung cancer	1.73e-05	0.000213	CcSEcCtD
Atazanavir—Urticaria—Methotrexate—lung cancer	1.68e-05	0.000207	CcSEcCtD
Atazanavir—Body temperature increased—Methotrexate—lung cancer	1.67e-05	0.000206	CcSEcCtD
Atazanavir—Abdominal pain—Methotrexate—lung cancer	1.67e-05	0.000206	CcSEcCtD
Atazanavir—Musculoskeletal discomfort—Doxorubicin—lung cancer	1.67e-05	0.000205	CcSEcCtD
Atazanavir—Insomnia—Doxorubicin—lung cancer	1.66e-05	0.000204	CcSEcCtD
Atazanavir—Dyspnoea—Doxorubicin—lung cancer	1.63e-05	0.000201	CcSEcCtD
Atazanavir—Somnolence—Doxorubicin—lung cancer	1.63e-05	0.0002	CcSEcCtD
Atazanavir—Dyspepsia—Doxorubicin—lung cancer	1.61e-05	0.000198	CcSEcCtD
Atazanavir—Decreased appetite—Doxorubicin—lung cancer	1.59e-05	0.000196	CcSEcCtD
Atazanavir—Gastrointestinal disorder—Doxorubicin—lung cancer	1.58e-05	0.000194	CcSEcCtD
Atazanavir—Fatigue—Doxorubicin—lung cancer	1.58e-05	0.000194	CcSEcCtD
Atazanavir—Pain—Doxorubicin—lung cancer	1.56e-05	0.000193	CcSEcCtD
Atazanavir—Constipation—Doxorubicin—lung cancer	1.56e-05	0.000193	CcSEcCtD
Atazanavir—Hypersensitivity—Methotrexate—lung cancer	1.56e-05	0.000192	CcSEcCtD
Atazanavir—Asthenia—Methotrexate—lung cancer	1.52e-05	0.000187	CcSEcCtD
Atazanavir—Feeling abnormal—Doxorubicin—lung cancer	1.51e-05	0.000186	CcSEcCtD
Atazanavir—Gastrointestinal pain—Doxorubicin—lung cancer	1.5e-05	0.000184	CcSEcCtD
Atazanavir—Pruritus—Methotrexate—lung cancer	1.5e-05	0.000184	CcSEcCtD
Atazanavir—Urticaria—Doxorubicin—lung cancer	1.45e-05	0.000179	CcSEcCtD
Atazanavir—Body temperature increased—Doxorubicin—lung cancer	1.45e-05	0.000178	CcSEcCtD
Atazanavir—Abdominal pain—Doxorubicin—lung cancer	1.45e-05	0.000178	CcSEcCtD
Atazanavir—Diarrhoea—Methotrexate—lung cancer	1.45e-05	0.000178	CcSEcCtD
Atazanavir—Dizziness—Methotrexate—lung cancer	1.4e-05	0.000172	CcSEcCtD
Atazanavir—Hypersensitivity—Doxorubicin—lung cancer	1.35e-05	0.000166	CcSEcCtD
Atazanavir—Vomiting—Methotrexate—lung cancer	1.34e-05	0.000165	CcSEcCtD
Atazanavir—Rash—Methotrexate—lung cancer	1.33e-05	0.000164	CcSEcCtD
Atazanavir—Dermatitis—Methotrexate—lung cancer	1.33e-05	0.000164	CcSEcCtD
Atazanavir—Headache—Methotrexate—lung cancer	1.32e-05	0.000163	CcSEcCtD
Atazanavir—Asthenia—Doxorubicin—lung cancer	1.31e-05	0.000162	CcSEcCtD
Atazanavir—Pruritus—Doxorubicin—lung cancer	1.29e-05	0.000159	CcSEcCtD
Atazanavir—Nausea—Methotrexate—lung cancer	1.26e-05	0.000155	CcSEcCtD
Atazanavir—Diarrhoea—Doxorubicin—lung cancer	1.25e-05	0.000154	CcSEcCtD
Atazanavir—Dizziness—Doxorubicin—lung cancer	1.21e-05	0.000149	CcSEcCtD
Atazanavir—Vomiting—Doxorubicin—lung cancer	1.16e-05	0.000143	CcSEcCtD
Atazanavir—Rash—Doxorubicin—lung cancer	1.15e-05	0.000142	CcSEcCtD
Atazanavir—Dermatitis—Doxorubicin—lung cancer	1.15e-05	0.000142	CcSEcCtD
Atazanavir—Headache—Doxorubicin—lung cancer	1.15e-05	0.000141	CcSEcCtD
Atazanavir—Nausea—Doxorubicin—lung cancer	1.09e-05	0.000134	CcSEcCtD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—lung cancer	7.94e-06	0.000327	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	7.8e-06	0.000322	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—MTMR3—lung cancer	7.8e-06	0.000321	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2A7—lung cancer	7.76e-06	0.00032	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	7.73e-06	0.000319	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—lung cancer	7.7e-06	0.000317	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—lung cancer	7.68e-06	0.000317	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PGAM1—lung cancer	7.6e-06	0.000313	CbGpPWpGaD
Atazanavir—ABCC1—Transmembrane transport of small molecules—RAF1—lung cancer	7.6e-06	0.000313	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—SDC4—lung cancer	7.59e-06	0.000313	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ATP5H—lung cancer	7.42e-06	0.000306	CbGpPWpGaD
Atazanavir—CYP3A4—Biological oxidations—POMC—lung cancer	7.4e-06	0.000305	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HES1—lung cancer	7.33e-06	0.000302	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—lung cancer	7.32e-06	0.000302	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2A7—lung cancer	7.25e-06	0.000299	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—STK11—lung cancer	7.18e-06	0.000296	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—lung cancer	7.12e-06	0.000294	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—SDC4—lung cancer	7.09e-06	0.000292	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—APOA1—lung cancer	7.02e-06	0.00029	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—lung cancer	6.94e-06	0.000286	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—RRM1—lung cancer	6.92e-06	0.000285	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTA3—lung cancer	6.92e-06	0.000285	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ERCC2—lung cancer	6.85e-06	0.000283	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PTEN—lung cancer	6.74e-06	0.000278	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	6.72e-06	0.000277	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ERBB3—lung cancer	6.7e-06	0.000276	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTP1—lung cancer	6.64e-06	0.000274	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PLBD1—lung cancer	6.61e-06	0.000273	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—AVP—lung cancer	6.6e-06	0.000272	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—lung cancer	6.56e-06	0.00027	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—B4GALT5—lung cancer	6.5e-06	0.000268	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CAT—lung cancer	6.46e-06	0.000267	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—RRM1—lung cancer	6.46e-06	0.000266	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTA3—lung cancer	6.46e-06	0.000266	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—EP300—lung cancer	6.43e-06	0.000265	CbGpPWpGaD
Atazanavir—ABCC1—Disease—TERT—lung cancer	6.42e-06	0.000265	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CG—lung cancer	6.41e-06	0.000264	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—lung cancer	6.38e-06	0.000263	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTA4—lung cancer	6.33e-06	0.000261	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ABCB1—lung cancer	6.29e-06	0.000259	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—lung cancer	6.24e-06	0.000257	CbGpPWpGaD
Atazanavir—ABCC1—Disease—FGFR1—lung cancer	6.24e-06	0.000257	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—TYMS—lung cancer	6.18e-06	0.000255	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTA2—lung cancer	6.16e-06	0.000254	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HIF1A—lung cancer	6.14e-06	0.000253	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—GSTM1—lung cancer	6.1e-06	0.000252	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—POMC—lung cancer	6.1e-06	0.000252	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—B4GALT5—lung cancer	6.07e-06	0.00025	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HSD17B10—lung cancer	6.05e-06	0.000249	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTA1—lung cancer	5.95e-06	0.000245	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—CREBBP—lung cancer	5.94e-06	0.000245	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APOA1—lung cancer	5.93e-06	0.000244	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTA4—lung cancer	5.91e-06	0.000244	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—lung cancer	5.9e-06	0.000243	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ABCC3—lung cancer	5.88e-06	0.000242	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CYP1A1—lung cancer	5.79e-06	0.000239	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—lung cancer	5.78e-06	0.000238	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTA2—lung cancer	5.76e-06	0.000237	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ERCC2—lung cancer	5.74e-06	0.000237	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AKR1C1—lung cancer	5.69e-06	0.000235	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CD—lung cancer	5.64e-06	0.000232	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CKB—lung cancer	5.62e-06	0.000232	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—ALB—lung cancer	5.56e-06	0.000229	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTA1—lung cancer	5.56e-06	0.000229	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—UGT1A1—lung cancer	5.53e-06	0.000228	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCC3—lung cancer	5.49e-06	0.000226	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—lung cancer	5.42e-06	0.000223	CbGpPWpGaD
Atazanavir—ABCC1—Disease—KIT—lung cancer	5.41e-06	0.000223	CbGpPWpGaD
Atazanavir—ABCC1—Disease—APC—lung cancer	5.41e-06	0.000223	CbGpPWpGaD
Atazanavir—ABCC1—Disease—EGF—lung cancer	5.35e-06	0.000221	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GNG11—lung cancer	5.33e-06	0.00022	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AKR1C1—lung cancer	5.32e-06	0.000219	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CNDP2—lung cancer	5.29e-06	0.000218	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTM2—lung cancer	5.29e-06	0.000218	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—lung cancer	5.24e-06	0.000216	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—UGT1A1—lung cancer	5.16e-06	0.000213	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—MTMR3—lung cancer	5.14e-06	0.000212	CbGpPWpGaD
Atazanavir—ABCC1—Disease—BRAF—lung cancer	5.09e-06	0.00021	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALDOA—lung cancer	5.08e-06	0.000209	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—APOA1—lung cancer	5.04e-06	0.000208	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6R—lung cancer	5.03e-06	0.000207	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CREBBP—lung cancer	5.02e-06	0.000207	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PGAM1—lung cancer	5.01e-06	0.000207	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GNG11—lung cancer	4.98e-06	0.000205	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—APOA1—lung cancer	4.97e-06	0.000205	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—APOA1—lung cancer	4.95e-06	0.000204	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NCOA3—lung cancer	4.93e-06	0.000203	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CB—lung cancer	4.91e-06	0.000203	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTGS2—lung cancer	4.87e-06	0.000201	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ABCG2—lung cancer	4.79e-06	0.000198	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ADCY1—lung cancer	4.79e-06	0.000198	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MAP2K1—lung cancer	4.79e-06	0.000197	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2A7—lung cancer	4.78e-06	0.000197	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CD—lung cancer	4.76e-06	0.000196	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	4.75e-06	0.000196	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALDOA—lung cancer	4.74e-06	0.000196	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—HPGDS—lung cancer	4.7e-06	0.000194	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ENO2—lung cancer	4.7e-06	0.000194	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—SDC4—lung cancer	4.68e-06	0.000193	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PPP2R1B—lung cancer	4.67e-06	0.000193	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NCOA3—lung cancer	4.6e-06	0.00019	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTT1—lung cancer	4.56e-06	0.000188	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CG—lung cancer	4.53e-06	0.000187	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CG—lung cancer	4.52e-06	0.000187	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GCLC—lung cancer	4.51e-06	0.000186	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2A6—lung cancer	4.51e-06	0.000186	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ADCY1—lung cancer	4.48e-06	0.000185	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCG2—lung cancer	4.48e-06	0.000185	CbGpPWpGaD
Atazanavir—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—lung cancer	4.42e-06	0.000182	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ENO2—lung cancer	4.39e-06	0.000181	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—HPGDS—lung cancer	4.39e-06	0.000181	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PPP2R1B—lung cancer	4.36e-06	0.00018	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—POMC—lung cancer	4.31e-06	0.000178	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—POMC—lung cancer	4.31e-06	0.000178	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ENO1—lung cancer	4.27e-06	0.000176	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—CREBBP—lung cancer	4.27e-06	0.000176	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MDM2—lung cancer	4.26e-06	0.000176	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—RRM1—lung cancer	4.26e-06	0.000176	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTA3—lung cancer	4.26e-06	0.000176	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTT1—lung cancer	4.26e-06	0.000176	CbGpPWpGaD
Atazanavir—ABCC1—Disease—RAF1—lung cancer	4.25e-06	0.000175	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PTEN—lung cancer	4.25e-06	0.000175	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GCLC—lung cancer	4.21e-06	0.000174	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2A6—lung cancer	4.21e-06	0.000174	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—CREBBP—lung cancer	4.2e-06	0.000173	CbGpPWpGaD
Atazanavir—ABCC1—Disease—ERBB2—lung cancer	4.2e-06	0.000173	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—CREBBP—lung cancer	4.19e-06	0.000173	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MTOR—lung cancer	4.15e-06	0.000171	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CB—lung cancer	4.15e-06	0.000171	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CD4—lung cancer	4.14e-06	0.000171	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTGS2—lung cancer	4.11e-06	0.000169	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—EP300—lung cancer	4.05e-06	0.000167	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—B4GALT5—lung cancer	4.01e-06	0.000165	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—ALB—lung cancer	4e-06	0.000165	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ENO1—lung cancer	3.99e-06	0.000165	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CD—lung cancer	3.98e-06	0.000164	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CD—lung cancer	3.98e-06	0.000164	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—ALB—lung cancer	3.93e-06	0.000162	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—ALB—lung cancer	3.93e-06	0.000162	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTA4—lung cancer	3.9e-06	0.000161	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP2E1—lung cancer	3.83e-06	0.000158	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTA2—lung cancer	3.8e-06	0.000157	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—NQO1—lung cancer	3.79e-06	0.000156	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTA1—lung cancer	3.66e-06	0.000151	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCC3—lung cancer	3.62e-06	0.000149	CbGpPWpGaD
Atazanavir—ABCB1—Transmembrane transport of small molecules—RAF1—lung cancer	3.61e-06	0.000149	CbGpPWpGaD
Atazanavir—ABCC1—Disease—CDKN1A—lung cancer	3.59e-06	0.000148	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PTEN—lung cancer	3.58e-06	0.000148	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP2E1—lung cancer	3.58e-06	0.000148	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—NQO1—lung cancer	3.54e-06	0.000146	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKR1C1—lung cancer	3.51e-06	0.000145	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CB—lung cancer	3.47e-06	0.000143	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CB—lung cancer	3.47e-06	0.000143	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTGS2—lung cancer	3.44e-06	0.000142	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—lung cancer	3.43e-06	0.000142	CbGpPWpGaD
Atazanavir—ABCC1—Disease—EP300—lung cancer	3.42e-06	0.000141	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—STK11—lung cancer	3.42e-06	0.000141	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—UGT1A1—lung cancer	3.41e-06	0.00014	CbGpPWpGaD
Atazanavir—ABCC1—Disease—SRC—lung cancer	3.32e-06	0.000137	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GNG11—lung cancer	3.28e-06	0.000135	CbGpPWpGaD
Atazanavir—ABCC1—Disease—STAT3—lung cancer	3.21e-06	0.000132	CbGpPWpGaD
Atazanavir—ABCC1—Disease—NRAS—lung cancer	3.2e-06	0.000132	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—STK11—lung cancer	3.19e-06	0.000132	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTP1—lung cancer	3.16e-06	0.00013	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALDOA—lung cancer	3.13e-06	0.000129	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CAT—lung cancer	3.08e-06	0.000127	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MAPK3—lung cancer	3.06e-06	0.000126	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NCOA3—lung cancer	3.04e-06	0.000125	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PTEN—lung cancer	3e-06	0.000124	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—lung cancer	3e-06	0.000123	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—PIK3CA—lung cancer	2.99e-06	0.000123	CbGpPWpGaD
Atazanavir—ABCC1—Disease—MYC—lung cancer	2.98e-06	0.000123	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ADCY1—lung cancer	2.95e-06	0.000122	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCG2—lung cancer	2.95e-06	0.000122	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTP1—lung cancer	2.95e-06	0.000122	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—TYMS—lung cancer	2.94e-06	0.000121	CbGpPWpGaD
Atazanavir—ABCC1—Disease—EGFR—lung cancer	2.91e-06	0.00012	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—GSTM1—lung cancer	2.9e-06	0.00012	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ENO2—lung cancer	2.9e-06	0.000119	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—HPGDS—lung cancer	2.9e-06	0.000119	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PPP2R1B—lung cancer	2.88e-06	0.000119	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CAT—lung cancer	2.87e-06	0.000118	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—EP300—lung cancer	2.86e-06	0.000118	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—EP300—lung cancer	2.86e-06	0.000118	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTT1—lung cancer	2.81e-06	0.000116	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ABCB1—lung cancer	2.79e-06	0.000115	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2A6—lung cancer	2.78e-06	0.000114	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GCLC—lung cancer	2.78e-06	0.000114	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CYP1A1—lung cancer	2.75e-06	0.000114	CbGpPWpGaD
Atazanavir—ABCC1—Disease—KRAS—lung cancer	2.75e-06	0.000113	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—TYMS—lung cancer	2.74e-06	0.000113	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ERCC2—lung cancer	2.73e-06	0.000113	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—GSTM1—lung cancer	2.71e-06	0.000112	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ENO1—lung cancer	2.63e-06	0.000109	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CYP1A1—lung cancer	2.57e-06	0.000106	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ERCC2—lung cancer	2.55e-06	0.000105	CbGpPWpGaD
Atazanavir—ABCC1—Disease—PIK3CA—lung cancer	2.53e-06	0.000104	CbGpPWpGaD
Atazanavir—SLCO1B3—Metabolism—AKT1—lung cancer	2.45e-06	0.000101	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—APOA1—lung cancer	2.36e-06	9.74e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP2E1—lung cancer	2.36e-06	9.73e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—HRAS—lung cancer	2.34e-06	9.64e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—NQO1—lung cancer	2.33e-06	9.63e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—IL6—lung cancer	2.24e-06	9.23e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—APOA1—lung cancer	2.21e-06	9.1e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CG—lung cancer	2.16e-06	8.89e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—PIK3CA—lung cancer	2.12e-06	8.73e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—lung cancer	2.11e-06	8.71e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—STK11—lung cancer	2.1e-06	8.68e-05	CbGpPWpGaD
Atazanavir—ABCC1—Disease—AKT1—lung cancer	2.07e-06	8.52e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—POMC—lung cancer	2.05e-06	8.46e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CG—lung cancer	2.01e-06	8.31e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—CREBBP—lung cancer	2e-06	8.24e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTP1—lung cancer	1.95e-06	8.03e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—POMC—lung cancer	1.92e-06	7.91e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CD—lung cancer	1.9e-06	7.82e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CAT—lung cancer	1.89e-06	7.81e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—ALB—lung cancer	1.87e-06	7.72e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—CREBBP—lung cancer	1.87e-06	7.7e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ABCB1—lung cancer	1.84e-06	7.6e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—TYMS—lung cancer	1.81e-06	7.46e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—GSTM1—lung cancer	1.79e-06	7.38e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CD—lung cancer	1.77e-06	7.3e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—ALB—lung cancer	1.75e-06	7.21e-05	CbGpPWpGaD
Atazanavir—ABCC1—Metabolism—AKT1—lung cancer	1.73e-06	7.13e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CYP1A1—lung cancer	1.7e-06	6.99e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ERCC2—lung cancer	1.68e-06	6.94e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CB—lung cancer	1.65e-06	6.81e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTGS2—lung cancer	1.64e-06	6.75e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CB—lung cancer	1.54e-06	6.36e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTGS2—lung cancer	1.53e-06	6.31e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—APOA1—lung cancer	1.46e-06	6e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PTEN—lung cancer	1.43e-06	5.89e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—EP300—lung cancer	1.36e-06	5.61e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PTEN—lung cancer	1.33e-06	5.5e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CG—lung cancer	1.33e-06	5.48e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—EP300—lung cancer	1.27e-06	5.24e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—POMC—lung cancer	1.26e-06	5.21e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—CREBBP—lung cancer	1.23e-06	5.08e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CD—lung cancer	1.17e-06	4.82e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—ALB—lung cancer	1.15e-06	4.75e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CB—lung cancer	1.02e-06	4.2e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTGS2—lung cancer	1.01e-06	4.16e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—PIK3CA—lung cancer	1.01e-06	4.15e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—PIK3CA—lung cancer	9.41e-07	3.88e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PTEN—lung cancer	8.8e-07	3.63e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—EP300—lung cancer	8.39e-07	3.46e-05	CbGpPWpGaD
Atazanavir—ABCB1—Metabolism—AKT1—lung cancer	8.23e-07	3.39e-05	CbGpPWpGaD
Atazanavir—CYP2C9—Metabolism—AKT1—lung cancer	7.69e-07	3.17e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—PIK3CA—lung cancer	6.21e-07	2.56e-05	CbGpPWpGaD
Atazanavir—CYP3A4—Metabolism—AKT1—lung cancer	5.07e-07	2.09e-05	CbGpPWpGaD
